0001104659-20-000769.txt : 20200103 0001104659-20-000769.hdr.sgml : 20200103 20200103145517 ACCESSION NUMBER: 0001104659-20-000769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prener Anne CENTRAL INDEX KEY: 0001797917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 20504759 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS STREET 2: 399 BINNEY STREET SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2019-12-31 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001797917 Prener Anne C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 9.50 2019-12-31 4 A 0 50000 0 A 2029-12-30 Common Stock 50000 50000 D This option shall vest in equal quarterly installments over the twelve quarters following the grant date. /s/ Joanne M. Protano, Attorney-in-Fact 2020-01-03